Covestor’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111K | Sell |
341
-74
| -18% | -$24.1K | 0.07% | 485 |
|
|
2025
Q1 | $112K | Sell |
415
-43
| -9% | -$11.6K | 0.07% | 404 |
|
|
2024
Q4 | $108K | Buy |
458
+1
| +0.2% | +$236 | 0.07% | 479 |
|
|
2024
Q3 | $126K | Sell |
457
-319
| -41% | -$88K | 0.08% | 389 |
|
|
2024
Q2 | $189K | Buy |
776
+44
| +6% | +$10.7K | 0.12% | 174 |
|
|
2024
Q1 | $110K | Buy |
732
+375
| +105% | +$56.4K | 0.07% | 474 |
|
|
2023
Q4 | $68K | Buy |
357
+293
| +458% | +$55.8K | 0.05% | 706 |
|
|
2023
Q3 | $11K | Sell |
64
-3
| -4% | -$516 | 0.01% | 1355 |
|
|
2023
Q2 | $13K | Buy |
67
+1
| +2% | +$194 | 0.01% | 1311 |
|
|
2023
Q1 | $13K | Sell |
66
-15
| -19% | -$2.96K | 0.01% | 1173 |
|
|
2022
Q4 | $19K | Sell |
81
-314
| -79% | -$73.7K | 0.02% | 1042 |
|
|
2022
Q3 | $79K | Buy |
395
+300
| +316% | +$60K | 0.07% | 477 |
|
|
2022
Q2 | $14K | Buy |
95
+2
| +2% | +$295 | 0.01% | 1067 |
|
|
2022
Q1 | $15K | Buy |
93
+37
| +66% | +$5.97K | 0.01% | 1138 |
|
|
2021
Q4 | $10K | Buy |
+56
| New | +$10K | 0.01% | 1010 |
|